Carcinosarcoma of the ovary

Area of Science:

• Gynecologic Oncology
• Pathology
• Clinical Management

Background:

• Ovarian carcinosarcoma is a rare and aggressive gynecologic malignancy.
• Limited data exists on the management and outcomes of this disease.

Purpose of the Study:

• To report the experience in managing patients with ovarian carcinosarcoma.
• To analyze prognostic factors and treatment outcomes in a large patient cohort.

Main Methods:

• Retrospective analysis of 40 patients with ovarian carcinosarcoma treated at a single institution.
• Review of histopathology, clinical presentation, surgical findings, and treatment regimens.
• Survival analysis based on FIGO stage, residual disease, and chemotherapy response.

Main Results:

• The median age was 65 years, with 80% presenting at FIGO stage III/IV.
• Bulk residual disease after surgery was associated with a worse prognosis (P=0.045).
• Platinum-based chemotherapy yielded limited responses: 9.4% complete response, 31% partial response.
• Overall censored median survival was 8.7 months, with 1- and 5-year survival rates of 40% and 7.5% respectively.

Conclusions:

• Ovarian carcinosarcoma is aggressive, with advanced stage and residual disease being poor prognostic indicators.
• Current platinum-based chemotherapy regimens demonstrate limited effectiveness in achieving durable responses.
• Further research is needed to identify more effective therapeutic strategies for ovarian carcinosarcoma.